Published in
Elsevier, EClinicalMedicine, p. 101946, 2023
DOI: 10.1016/j.eclinm.2023.101946
Links
Tools
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
Journal article published in 2023 by
Lucy E. M. Finnigan 
,
Mark Philip Cassar,
Margaret James Koziel,
Joel Pradines,
Hanan Lamlum,
Karim Azer,
Dan Kirby,
Hugh Montgomery,
Stefan Neubauer,
Ladislav Valkovič,
Betty Raman
,
Mark Philip Cassar,
Margaret James Koziel,
Joel Pradines,
Hanan Lamlum,
Karim Azer,
Dan Kirby,
Hugh Montgomery,
Stefan Neubauer,
Ladislav Valkovič,
Betty Raman
This paper is made freely available by the publisher.
Full text: Download
Data provided by 